We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$13.4B
AUM Growth
-$1.18B
Cap. Flow
-$624M
Cap. Flow %
-4.67%
Top 10 Hldgs %
7.94%
Holding
1,057
New
56
Increased
305
Reduced
416
Closed
75

Top Buys

Rank Stock Value
1
IOSP icon
Innospec
IOSP
+$25.1M
2
HAE icon
Haemonetics
HAE
+$24.2M
3
CALX icon
Calix
CALX
+$22.2M
4
MXCT icon
MaxCyte
MXCT
+$21.3M
5
FRG
Franchise Group, Inc.
FRG
+$21.3M

Sector Composition

Rank Sector Weight
1 Industrials 25.4%
2 Technology 20.93%
3 Financials 15.39%
4 Consumer Discretionary 13.63%
5 Materials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUNL
1026
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
-4,038
Closed -$807K
LCI
1027
DELISTED
Lannett Company, Inc.
LCI
-10,284
Closed -$192K
SPNE
1028
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
-128,000
Closed -$2.63M
DS
1029
DELISTED
Drive Shack Inc.
DS
-434,326
Closed -$1.44M
MANT
1030
DELISTED
Mantech International Corp
MANT
-3,384
Closed -$293K
ATC
1031
DELISTED
Atotech Limited
ATC
-432,269
Closed -$11M
MILE
1032
DELISTED
Metromile, Inc. Common Stock
MILE
-150,000
Closed -$1.37M
ACBI
1033
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
-238,973
Closed -$6.08M
CSLT
1034
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
-1,356,552
Closed -$3.57M
MGLN
1035
DELISTED
Magellan Health Services, Inc.
MGLN
-8,265
Closed -$779K
ITMR
1036
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
-63,000
Closed -$1.48M
ICBK
1037
DELISTED
County Bancorp, Inc. Common Stock
ICBK
-92,997
Closed -$3.16M
CVA
1038
DELISTED
Covanta Holding Corporation
CVA
-848,189
Closed -$14.9M
FLXN
1039
DELISTED
Flexion Therapeutics, Inc.
FLXN
-451,037
Closed -$3.71M
EBSB
1040
DELISTED
Meridian Bancorp, Inc.
EBSB
-82,500
Closed -$1.69M
SIC
1041
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
-768,646
Closed -$7.22M
SCR
1042
DELISTED
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
-177,710
Closed -$3.56M
GPX
1043
DELISTED
GP Strategies Corp.
GPX
-1,520,861
Closed -$23.9M
XEC
1044
DELISTED
CIMAREX ENERGY CO
XEC
-285,000
Closed -$20.6M
JAX
1045
DELISTED
J. Alexander's Holdings, Inc.
JAX
-498,136
Closed -$5.8M
CTAC
1046
DELISTED
Cerberus Telecom Acquisition Corp.
CTAC
-166,800
Closed -$1.66M
NWHM
1047
DELISTED
THE NEW HOME COMPANY INC.
NWHM
-1,037,205
Closed -$6.09M
CORE
1048
DELISTED
Core Mark Holding Co., Inc.
CORE
-5,057
Closed -$228K
SHSP
1049
DELISTED
SharpSpring, Inc.
SHSP
-104,700
Closed -$1.77M
SYKE
1050
DELISTED
SYKES Enterprises Inc
SYKE
-31,526
Closed -$1.69M

Similar funds

Royce & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Royce & Associates held 1,057 positions worth $13.4B, down 8.1% from $14.6B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Royce & Associates withdrew a net $624M in Q3 2021, closing 75 positions and reducing 416 holdings. Its most notable exit was SmileDirectClub, Inc. Class A Common Stock, an estimated $32.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in Calix worth $23.8M.

  • Royce & Associates's largest Q3 2021 buy was Calix: 480,993 shares worth $23.8M.
  • Royce & Associates added most to Innospec in Q3 2021, an estimated $25.1M increase.
  • Royce & Associates's biggest Q3 2021 reduction was Kulicke & Soffa, cutting an estimated $37.4M.
  • Royce & Associates fully exited SmileDirectClub, Inc. Class A Common Stock in Q3 2021, selling an estimated $32.3M.
  • Royce & Associates's ten largest holdings make up 7.9% of its $13.4B portfolio in Q3 2021.
  • Royce & Associates opened 56 new positions and closed 75 in Q3 2021.
  • Royce & Associates's portfolio value fell 8.1% quarter-over-quarter to $13.4B.

Based on Royce & Associates's 13F filing for Q3 2021, filed 10 Nov 2021.